Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV.
NCT05755659
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
3000
Enrollment
OTHER
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Fosaprepitant Dimeglumine for Injection
Sponsor
Xijing Hospital